Barbara Gayle Duncan, Director at Jounce Therapeutics, Inc. (JNCE), sold 10,000 shares at $10.50 ($100K) on 2020-09-15, disclosed to the SEC on 2020-09-16.
Open-market sale of $100k JNCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.50 | 5,000 | $48K | 47.5% |
| 2 | $10.50 | 5,000 | $53K | 52.5% |
| Total | $10.00 avg | 10,000 | $100K | 100% |
| Filing → |
| GNMX | BUY | 2017-10-18 | $150K | — | Filing → |
| ICPT | SELL | 2016-10-05 | $24K | — | Filing → |
| ICPT | SELL | 2016-07-07 | $21K | — | Filing → |